XenoPort, Inc.
(NASDAQ : XNPT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.69%44.050.9%$805.20m
JNJJohnson & Johnson
0.62%142.860.6%$795.84m
MRKMerck & Co., Inc.
0.44%71.090.6%$480.99m
ABBVAbbVie, Inc.
-0.50%92.222.2%$409.76m
LLYEli Lilly and Company
0.20%106.281.0%$349.52m
BMYBristol-Myers Squibb Company
0.81%62.251.4%$275.08m
NVSNovartis AG Sponsored ADR
-0.61%85.450.2%$126.52m
AZNAstraZeneca PLC Sponsored ADR
-0.09%37.691.3%$117.83m
GSKGlaxoSmithKline plc Sponsored ADR
1.08%40.300.2%$78.46m
NVONovo Nordisk A/S Sponsored ADR Class B
0.36%47.670.1%$50.90m
SNYSanofi Sponsored ADR
-1.18%43.630.2%$36.98m
LCILannett Company, Inc.
-8.64%5.0337.0%$10.63m
AKTXAkari Therapeutics Plc Sponsored ADR
0.96%2.111.7%$0.13m
EPIXESSA Pharma Inc
-11.00%2.670.1%$0.04m

Company Profile

XenoPort, Inc. operates as a biopharmaceutical company. Its products include horizant and regnite. The company is headquartered in was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on May 19, 1999 and is headquartered in Redwood City, CA.